4//SEC Filing
Lafond Kevin G 4
Accession 0001209191-20-001176
CIK 0001107421other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 5:09 PM ET
Size
7.9 KB
Accession
0001209191-20-001176
Insider Transaction Report
Form 4
Lafond Kevin G
Vice Pres., Treasurer, & CAO
Transactions
- Award
Employee Stock Option (right to buy)
2019-12-31+48,000→ 48,000 totalExercise: $4.72Exp: 2029-12-31→ Common Stock (48,000 underlying) - Sale
Common Stock
2020-01-02$4.55/sh−21,570$98,144→ 63,985 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person to satisfy withholding tax obligations upon the vesting of restricted stock grants.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.46 to $4.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]1/12th of the shares underlying this option will vest in equal quarterly installments commencing one quarterly period after 12/31/2019.
Documents
Issuer
ZIOPHARM ONCOLOGY INC
CIK 0001107421
Entity typeother
Related Parties
1- filerCIK 0001429559
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 5:09 PM ET
- Size
- 7.9 KB